Article by: Raza Lawrence and Ivy Perez-Bader After more than fifty years of classification alongside heroin and LSD, cannabis may soon occupy the same legal category as ketamine and Tylenol with codeine. Following an Executive Order issued by President Trump in December 2025 directing the Attorney General to complete the rescheduling rulemaking process in an expeditious…
Article by: Raza Lawrence and Ivy Perez-Bader Federal cannabis rescheduling has been widely discussed as a tax, banking, and criminal law inflection point. Far less attention has been paid to what may ultimately be its most consequential effect: a re-centering of federal food and drug law in an industry that has largely developed outside of it.…
Article by: Lonnie Rosenwald and Carla Pareja Paris Artificial intelligence has become central to the longevity industry. Companies increasingly rely on machine-learning models to analyze biomarkers, genomic data, wearable device outputs, and other health-related inputs to predict disease risk, biological age, or therapeutic response. Many tools, such as the new ChatGPT Health product, invite consumers…